Close

Dr Rebecca Glover

Assistant Professor

United Kingdom

An interdisciplinary Assistant Professor at the London School of Hygiene and Tropical Medicine (LSHTM) in Antimicrobial Resistance, in the department of Health Services Research and Policy. I am a thought leader in antimicrobial resistance innovation policy, social and commercial determinants of health, and evaluation with a particular interest in complex systems research. I am Associate Convener of the Campbell and Cochrane Equity Methods Group, a founding member of the LSHTM Commercial Determinants Research Group, and I served as the Head of Economic, Social, and Political Sciences in the LSHTM AMR Centre from 2018-2022.

Affiliations

Department of Health Services Research and Policy
Faculty of Public Health and Policy

Centres

Antimicrobial Resistance Centre

Teaching

I am the Module Organiser for Applied Communicable Disease Control, a modern module using problem based learning and applied lecturing styles to provide students with up-to-date, usable skills for their future careers in field epidemiology, programme management, and disease control

Research

complex systems, complex evaluation, fast and slow pandemics, interactions between NCDs and IDs.

Selected Publications

Governing Integrated Health and Social Care: An Analysis of Experiences in Three European Countries.
EXLEY, J; GLOVER, R; Mccarey, M; Reed, S; Ahmed, A; Vrijhoef, H; Manacorda, T; Vaccaro, C; Longo, F; Stewart, E; MAYS, N; NOLTE, E;
2024
International journal of integrated care
Why is the UK subscription model for antibiotics considered successful?
GLOVER, RE; Singer, A; Roberts, AP; Kirchhelle, C;
2023
The Lancet Microbe
Meeting the governance challenges of integrated health and social care
EXLEY, J; GLOVER, R; McCarey, M; Reed, S; Ahmed, A; Vrijhoef, H; Manacorda, T; Stewart, E; MAYS, N; NOLTE, E;
2022
European Journal of Public Health
The antibiotic subscription model: fostering innovation or repackaging old drugs?
GLOVER, RE; Singer, AC; Roberts, AP; Kirchhelle, C;
2022
The Lancet. Microbe
Methodological guidance for incorporating equity when informing rapid-policy and guideline development.
Dewidar, O; Kawala, BA; Antequera, A; Tricco, AC; Tovey, D; Straus, S; GLOVER, R; Tufte, J; Magwood, O; Smith, M; Ooi, CP; Dion, A; Goetghebeur, M; Reveiz, L; Negrini, S; Tugwell, P; Petkovic, J; Welch, V; COVID-END Equity Task Force,;
2022
Journal of clinical epidemiology
Resources supporting trustworthy, rapid and equitable evidence synthesis and guideline development: results from the COVID-19 evidence network to support decision-making (COVID-END).
McCaul, M; Tovey, D; Young, T; Welch, V; Dewidar, O; Goetghebeur, M; Kredo, T; Tricco, AC; GLOVER, RE; Tufte, J; Qaseem, A; Ludovic, R; Morgan, RL; Vandvik, PO; Florez, ID; COVID-END Recommending, Synthesizing and Equity Wo,;
2022
Journal of clinical epidemiology
Sale of UK's Vaccine Manufacturing and Innovation Centre.
GLOVER, RE; Roberts, AP; Singer, AC; Kirchhelle, C;
2022
BMJ (Clinical research ed.)
See more information